التفاصيل البيبلوغرافية
| العنوان: |
Metastatic progression of breast cancer along with decreased mitochondrial cell death priming of breast cancer cells: a case report. |
| المؤلفون: |
Aka, Yeliz, Ozdemir, Hulya, Torun, Nese, Bolat, Filiz Aka, Kutuk, Ozgur |
| المصدر: |
Oxford Medical Case Reports; Mar2024, Vol. 2024 Issue 3, p1-4, 4p |
| مصطلحات موضوعية: |
METASTATIC breast cancer, BREAST cancer, CELL death, CANCER cells, MITOCHONDRIA, CANCER cell growth |
| مستخلص: |
Metastatic breast cancer remains to be a major cause of cancer-related deaths in women. Exploring the molecular mechanisms to identify targetable alterations in progressing breast cancer and developing functional tools to predict therapy response in these patients are needed. In this report, we present a case of breast cancer patient who progressed following surgery and adjuvant endocrine therapy. Radiological and pathological analyses revealed metastasis to liver and brain. Paired liquid biopsies demonstrated acquired ERBB2 mutations in addition to TP53 and PIK3CA mutations, which were also present before progression. BH3 profiling test demonstrated decreased mitochondrial cell death priming in CTCs of the patient after progression. In conclusion, novel personalized treatment strategies are needed to monitor metastatic breast cancer patients for better clinical benefit. [ABSTRACT FROM AUTHOR] |
|
Copyright of Oxford Medical Case Reports is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder